PTPA and neoplasm: Furthermore, with the intermittent fasting model, Minucci and his colleagues found that the combination of hypoglycemia and metformin (200 mg/kg) could inhibit tumor growth by activating PP2A, a tumor suppressor, in the absence of AMPK.